Literature DB >> 19356610

Effectiveness of Jeryl Lynn-containing vaccine in Spanish children.

Jesús Castilla1, Manuel García Cenoz, Maite Arriazu, Mirian Fernández-Alonso, Víctor Martínez-Artola, Jaione Etxeberria, Fátima Irisarri, Aurelio Barricarte.   

Abstract

We evaluated the effectiveness of the Jeryl Lynn strain vaccine in a large outbreak of mumps in Navarre, Spain, 2006-2008. Each of the 241 cases of mumps occurring in children over 15 months of age born between 1998 and 2005 was compared with 5 controls individually matched by sex, birth date, district of residence and paediatrician. Vaccination history was obtained blindly from clinical records. Conditional logistic regression was used to obtain the matched odds ratios (ORs), and effectiveness was calculated as 1-OR. Some 70% of cases had received one dose of measles-mumps-rubella vaccine, and 24% had received two doses. Overall vaccine effectiveness was 72% (95% CI, 39-87%). Two doses were more effective (83%; 54-94%) than a single dose (66%; 25-85%). Among vaccinated children, risk was higher in those who had received the first dose after 36 months of age (OR=3.1; 1.2-8.4) and those who had received the second dose 3 or more years before study enrolment (OR=10.2; 1.5-70.7). Early waning of immunity in children after the second dose may contribute to reduced vaccine effectiveness for mumps prevention.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19356610     DOI: 10.1016/j.vaccine.2009.02.001

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  13 in total

1.  Recent mumps outbreaks in vaccinated populations: no evidence of immune escape.

Authors:  Steven A Rubin; Malen A Link; Christian J Sauder; Cheryl Zhang; Laurie Ngo; Bert K Rima; W Paul Duprex
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  [Study of a population-wide epidemic outbreak of mumps virus G1 in Jerez de la Frontera (Spain)].

Authors:  Pascasio Peña González; José Almenara Barrios; Juan Carlos Morales Serna
Journal:  Aten Primaria       Date:  2011-10-21       Impact factor: 1.137

3.  Assessment of mumps virus-specific antibodies by different serological assays: which test correlates best with mumps immunity?

Authors:  R Allwinn; B Zeidler; K Steinhagen; E Rohwäder; S Wicker; H F Rabenau; H W Doerr
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-01       Impact factor: 3.267

4.  Close the gap for routine mumps vaccination in Japan.

Authors:  Taito Kitano
Journal:  Hum Vaccin Immunother       Date:  2020-06-12       Impact factor: 3.452

5.  Effectiveness of one dose of mumps vaccine against clinically diagnosed mumps in Guangzhou, China, 2006-2012.

Authors:  Chuanxi Fu; Jianxiong Xu; Yuanjun Cai; Qing He; Chunhuan Zhang; Jian Chen; Zhiqiang Dong; Wensui Hu; Hui Wang; Wei Zhu; Ming Wang
Journal:  Hum Vaccin Immunother       Date:  2013-08-16       Impact factor: 3.452

Review 6.  Vaccines for measles, mumps and rubella in children.

Authors:  Vittorio Demicheli; Alessandro Rivetti; Maria Grazia Debalini; Carlo Di Pietrantonj
Journal:  Cochrane Database Syst Rev       Date:  2012-02-15

Review 7.  Vaccines for measles, mumps, rubella, and varicella in children.

Authors:  Carlo Di Pietrantonj; Alessandro Rivetti; Pasquale Marchione; Maria Grazia Debalini; Vittorio Demicheli
Journal:  Cochrane Database Syst Rev       Date:  2021-11-22

8.  Loss of protective immunity of two-dose mumps-containing vaccine over time: concerns with the new strategy of the mumps immunization program in China.

Authors:  Danni Wang; Tingyue Nie; Fan Pan; Yao Wang; Jian Wang; Wei Qin
Journal:  Hum Vaccin Immunother       Date:  2021-02-05       Impact factor: 3.452

9.  Seroepidemiology of mumps in Europe (1996-2008): why do outbreaks occur in highly vaccinated populations?

Authors:  J Eriksen; I Davidkin; G Kafatos; N Andrews; C Barbara; D Cohen; A Duks; A Griskevicius; K Johansen; K Bartha; B Kriz; G Mitis; J Mossong; A Nardone; D O'Flanagan; F DE Ory; A Pistol; H Theeten; K Prosenc; M Slacikova; R Pebody
Journal:  Epidemiol Infect       Date:  2012-06-12       Impact factor: 4.434

10.  Vaccines for measles, mumps, rubella, and varicella in children.

Authors:  Carlo Di Pietrantonj; Alessandro Rivetti; Pasquale Marchione; Maria Grazia Debalini; Vittorio Demicheli
Journal:  Cochrane Database Syst Rev       Date:  2020-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.